STAT Plus: Alnylam and Dicerna, onetime rivals, announce a ceasefire
KRISTOFFER TRIPPLAAR/SIPA USA/AP
The two companies, which are both developing drugs using the Nobel-winning technique RNAi, announced an accord intended to harmonize two drug programs.


No hay comentarios:
Publicar un comentario